Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 75 years old (any gender) and are willing to sign a consent form after understanding what the trial involves
- You are well enough to carry out basic daily activities, with an activity/health status score in the acceptable range (confirm with trial site)
- You have been diagnosed with a specific type of pancreatic cancer called pancreatic ductal adenocarcinoma, confirmed by tissue testing or a combination of tissue testing and medical examination
- You are willing to have a routine blood marker test (CA19-9) and a small blood sample (2–3ml) taken to test for something called Lewis antigens, and you agree to attend follow-up appointments
- If you do not have pancreatic cancer, you may still be able to join a separate part of the study if you are aged 18–75, willing to sign a consent form, and agree to provide a small blood sample (2–3ml) for Lewis antigen testing
Who may not be able to join:
- You currently have another type of cancer at the same time as pancreatic cancer
- You have pancreatic cancer but there is no clear record of your cancer treatment plan available
- You have tested positive for HIV
- There are other reasons the research team believes make it unsuitable for you to join (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 18017317460
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To explore the prognosis of pancreatic cancer with the combination of the Lewis antigen test and the CA19-9 test
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.